Granules India gets nod for Fexofenadine Hydrochloride Tablets

22 Oct 2019 Evaluate

US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules India for Fexofenadine Hydrochloride Tablets USP, 60 mg and 180 mg (OTC). It is bioequivalent to the reference listed drug product (RLD), Allegra Allergy Tablets, 60 mg and 180 mg, of Sanofi-Aventis US LLC.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).

Granules India Share Price

592.55 -13.35 (-2.20%)
10-Jan-2025 15:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1785.10
Dr. Reddys Lab 1355.00
Cipla 1470.90
Lupin 2193.45
Zydus Lifesciences 1004.75
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.